newsfilter
← Latest News
Business Wire·

Kardigan Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Kardigan™, Inc. (NASDAQ:KARD) ("Kardigan"), a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments